| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |